A Post Marketing Observational Study of Activities of Daily Living in Advanced Parkinson's Disease Patients With Early Troublesome Motor Fluctuations and Treated With Duodopa - a Multi-country Study - MONOTREAT
Phase of Trial: Phase IV
Latest Information Update: 01 Jul 2017
Price : $35 *
At a glance
- Drugs Levodopa/carbidopa (Primary)
- Indications Parkinson's disease
- Focus Therapeutic Use
- Acronyms MONOTREAT
- Sponsors Abbott Laboratories; AbbVie
- 25 Aug 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 29 Oct 2014 Planned End Date changed from 1 Apr 2015 to 1 Jul 2015 as reported by ClinicalTrials.gov record .
- 29 Jul 2014 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.